Use of deamidated gliadin peptide (DGP) test kits as adjunctive to Tissue-transglutaminase IgA (TTG-IgA) for the diagnosis of celiac disease (CD) has been a controversial issue. The objectives of our study were to evaluate the diagnostic performance of DGP antibodies compared to TTG-IgA and to evaluate the correlation between DGP-antibodies titers and degree of enteropathy.
Deamidated Gliadin Antibodies: Do They Add to Tissue Transglutaminase-IgA Assay in Screening For Celiac Disease? / Abdulrahim, Ashraf; Fagih, Musa; Troncone, Riccardo; Bashir, Muhammed Salman; Asery, Ali; Alruwaithi, Muhannad; Al-Jurrayyan, Abdullah N; Al-Alallah, Ibrahim; Al-Hussaini, Abdulrahman. - In: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. - ISSN 0277-2116. - 72:5(2021), pp. e112-e118. [10.1097/MPG.0000000000003022]
Deamidated Gliadin Antibodies: Do They Add to Tissue Transglutaminase-IgA Assay in Screening For Celiac Disease?
Troncone, Riccardo;
2021
Abstract
Use of deamidated gliadin peptide (DGP) test kits as adjunctive to Tissue-transglutaminase IgA (TTG-IgA) for the diagnosis of celiac disease (CD) has been a controversial issue. The objectives of our study were to evaluate the diagnostic performance of DGP antibodies compared to TTG-IgA and to evaluate the correlation between DGP-antibodies titers and degree of enteropathy.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.